Design of clinical intelligent percutaneous myocardial laser revascularization operating platform software

Percutaneous transmyocardial laser revasculariztion (PMLR), a kind of new percutaneous coronary intervention based on transmyocardial laser revascularization (TMLR) is to improve the circulation of ischemia myocardium by laser myocardial revascularization from the cardiac cavity. In our previous research, the characteristic of laser transmission in myocardium including photon reflection, absorption and scattering was introduced. The photon state at the emission, transmission and disappearance stage, the processes of photon weight decay and the change of photon movement step and direction were described and simulated by using Monte Carlo method. All of the above were simulated by MATLAB, and the relationship between different optical property parameters, absorption coefficient, scattering coefficient, anisotropic coefficient, and photon energy density in myocardium was discussed. In this study simulation of photon transport using Monte Carlo operating platform was programmed by C++ language to investigate the influence of increasing photons on the simulation at different optical properties parameters and clinical intelligent PMLR operating platform was established to achieve the optimal number of laser holes, aperture, single hole perfusion, threshold power and corresponding parameters of each hole, which provided a reference for the operation program.

[1]  F. Zhang,et al.  Self-reported insomnia and coronary heart disease in the elderly , 2016, Clinical and experimental hypertension.

[2]  K. Davidson,et al.  Meta-analysis of perceived stress and its association with incident coronary heart disease. , 2012, The American journal of cardiology.

[3]  Q. She,et al.  One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease. , 2012, Journal of interventional cardiology.

[4]  A. Milano,et al.  Transmyocardial laser revascularization 12 years later. , 2010, Interactive cardiovascular and thoracic surgery.

[5]  C. Dintsios,et al.  Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease , 2008, GMS health technology assessment.

[6]  L. Sharples,et al.  Percutaneous myocardial laser revascularization in patients with refractory angina pectoris. , 2003, The American journal of cardiology.

[7]  Lang Li,et al.  Comparative Efficacy and Safety of Drug-Eluting Stent and Conventional Therapies in Coronary Heart Disease Patients with In-Stent Restenosis: A Meta-Analysis , 2013, Cell Biochemistry and Biophysics.

[8]  D. Dudek,et al.  [Left ventricular systolic function in patients with refractory angina pectoris treated with percutaneous myocardial laser revascularisation, results of long-term follow-up]. , 2004, Przeglad lekarski.

[9]  A. Coats,et al.  Cardiac and blood pressure responses to mental stress in reactive hypertensives. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.